These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 27050146
1. Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx. Wang C, Sturgis EM, Chen X, Zheng H, Wei Q, Li G. Oncotarget; 2016 May 03; 7(18):26444-53. PubMed ID: 27050146 [Abstract] [Full Text] [Related]
2. Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx. Guan X, Sturgis EM, Song X, Liu Z, El-Naggar AK, Wei Q, Li G. Cancer Lett; 2013 Apr 28; 330(2):233-40. PubMed ID: 23219900 [Abstract] [Full Text] [Related]
3. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Liu Z, Li G, Wei S, Niu J, El-Naggar AK, Sturgis EM, Wei Q. Cancer; 2010 Oct 15; 116(20):4753-60. PubMed ID: 20549817 [Abstract] [Full Text] [Related]
4. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC. Hong MJ, Choi YY, Jang JA, Jung HJ, Lee SY, Lee WK, Yoo SS, Lee J, Cha SI, Kim CH, Lee E, Jeon HS, Son JW, Park JY. J Thorac Oncol; 2013 Jun 15; 8(6):703-10. PubMed ID: 23470291 [Abstract] [Full Text] [Related]
5. Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies. Ma XP, Zhang T, Peng B, Yu L, Jiang de K. PLoS One; 2013 Jun 15; 8(11):e79584. PubMed ID: 24278149 [Abstract] [Full Text] [Related]
6. Association of microRNA polymorphisms with the risk of head and neck squamous cell carcinoma in a Chinese population: a case-control study. Miao L, Wang L, Zhu L, Du J, Zhu X, Niu Y, Wang R, Hu Z, Chen N, Shen H, Ma H. Chin J Cancer; 2016 Aug 11; 35(1):77. PubMed ID: 27515039 [Abstract] [Full Text] [Related]
7. MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population. Wei J, Zheng L, Liu S, Yin J, Wang L, Wang X, Shi Y, Shao A, Tang W, Ding G, Liu C, Chen S, Gu H. Hum Immunol; 2013 Sep 11; 74(9):1199-205. PubMed ID: 23792053 [Abstract] [Full Text] [Related]
8. TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx. Zhang C, Sturgis EM, Zheng H, Zafereo ME, Wei Q, Li G. Int J Cancer; 2014 Oct 01; 135(7):1615-24. PubMed ID: 24550071 [Abstract] [Full Text] [Related]
9. Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy. Chen X, Sturgis EM, Wang C, Cao X, Li Y, Wei Q, Li G. Oncotarget; 2016 Jun 07; 7(23):35015-25. PubMed ID: 27145460 [Abstract] [Full Text] [Related]
10. Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Zhou B, Wang K, Wang Y, Xi M, Zhang Z, Song Y, Zhang L. Mol Carcinog; 2011 Jul 07; 50(7):499-505. PubMed ID: 21319225 [Abstract] [Full Text] [Related]
11. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, Lee HS, Lee JS. J Thorac Cardiovasc Surg; 2012 Oct 07; 144(4):794-807. PubMed ID: 22818121 [Abstract] [Full Text] [Related]
12. Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy. Zhou B, Rao L, Peng Y, Wang Y, Chen Y, Song Y, Zhang L. Clin Chim Acta; 2010 Sep 06; 411(17-18):1287-90. PubMed ID: 20488170 [Abstract] [Full Text] [Related]
13. Contribution of microRNA-149, microRNA-146a, and microRNA-196a2 SNPs in colorectal cancer risk and clinicopathological features in Tunisia. Chayeb V, Mahjoub S, Zitouni H, Jrah-Harzallah H, Zouari K, Letaief R, Mahjoub T. Gene; 2018 Aug 05; 666():100-107. PubMed ID: 29715515 [Abstract] [Full Text] [Related]
14. Common genetic polymorphisms in pre-microRNAs and risk of bladder cancer. Deng S, Wang W, Li X, Zhang P. World J Surg Oncol; 2015 Oct 13; 13():297. PubMed ID: 26458899 [Abstract] [Full Text] [Related]
16. Prognostic role of microRNA polymorphisms in patients with advanced esophageal squamous cell carcinoma receiving platinum-based chemotherapy. Wu C, Li M, Hu C, Duan H. Cancer Chemother Pharmacol; 2014 Feb 13; 73(2):335-41. PubMed ID: 24288122 [Abstract] [Full Text] [Related]
17. Association between common genetic variants in pre-microRNAs and prognosis of advanced gastric cancer treated with chemotherapy. Tahara T, Okubo M, Shibata T, Kawamura T, Sumi K, Ishizuka T, Nagasaka M, Nakagawa Y, Arisawa T, Ohmiya N, Hirata I. Anticancer Res; 2014 Sep 13; 34(9):5199-204. PubMed ID: 25202115 [Abstract] [Full Text] [Related]
18. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, Miao R, Wang Y, Wang X, Shen H. Hum Mutat; 2009 Jan 13; 30(1):79-84. PubMed ID: 18634034 [Abstract] [Full Text] [Related]
19. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol. Arantes LM, Laus AC, Melendez ME, de Carvalho AC, Sorroche BP, De Marchi PR, Evangelista AF, Scapulatempo-Neto C, de Souza Viana L, Carvalho AL. Oncotarget; 2017 Feb 07; 8(6):9911-9921. PubMed ID: 28039483 [Abstract] [Full Text] [Related]
20. MicroRNA Gene Polymorphisms in Evaluating Therapeutic Efficacy After Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma. Qiu GP, Liu J. Genet Test Mol Biomarkers; 2016 Oct 07; 20(10):579-586. PubMed ID: 27525669 [Abstract] [Full Text] [Related] Page: [Next] [New Search]